"The company may consider future use in newly-diagnosed methylated patients in consultation with clinicians as further data becomes available" was the last sentence in the presso.
Why not? If I were a "methylated" patient, I'd want something better than temozolomide.
"The company may consider future use in newly-diagnosed...
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)